|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:453-457
© 2000 Mosby, Inc.
GENERAL THORACIC SURGERY |
From the Dipartimento di Scienze Mediche e Chirurgiche-Sezione di Clinica Chirurgica 4, University of Padua School of Medicine, Padova, Italy.
Address for reprints: Alberto Ruol, MD, Dipartimento di Scienze Mediche e Chirurgiche, Sezione di Clinica Chirurgica 4, University of Padua School of Medicine, Via Giustiniani, 2, 35128 Padova, Italy (E-mail: aruol{at}ux1.unipd.it ).
Objective: Postoperative chylothorax remains an uncommon but potentially life-threatening complication of esophagectomy for cancer, and the ideal management is still controversial. The aim of the study was to compare the outcomes of patients treated nonoperatively with those of patients promptly undergoing reoperation.
Methods: From 1980 to 1998, 1787 esophagectomies for esophageal or cardia cancer were performed, and 19 (1.1%) patients had postoperative chylothorax. We analyzed type of operation, surgical approach, delay of diagnosis of chylothorax, daily chest tube output, type of management, major complications, death, hospital stay, and final outcome.
Results: Of the 19 patients with chylothorax, 11 were initially managed nonoperatively (group A): 4 (36%) patients had spontaneous resolution of chylothorax, and the other 7 required reoperation for the persistence of a high-volume output. There were three infectious complications and one postoperative death in this group. No reliable predictive criteria of successful versus unsuccessful nonoperative management could be found. The 8 most recent patients underwent early reoperation (group B). All patients recovered, and no major complications possibly related to chylothorax or hospital deaths were observed. They were discharged after a median of 22 days (range, 12-85 days) compared with a median of 36 days (range, 21-64 days) for patients of group A.
Conclusions: Early thoracic duct ligation is the treatment of choice for chylothorax occurring after esophagectomy. Reoperation should be performed immediately after the diagnosis is made to avoid the complications related to nutritional and immunologic depletion caused by prolonged nonoperative treatment.
This article has been cited by other articles:
![]() |
J. B. Ammori, A. Pickens, A. C. Chang, and M. B. Orringer Tension Chylothorax Ann. Thorac. Surg., August 1, 2006; 82(2): 729 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Guillem, I. Papachristos, C. Peillon, and J.-P. Triboulet Etilefrine use in the management of post-operative chyle leaks in thoracic surgery Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 156 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riquet, F. Le Pimpec Barthes, R. Souilamas, and G. Hidden Thoracic duct tributaries from intrathoracic organs Ann. Thorac. Surg., March 1, 2002; 73(3): 892 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Hoffer, R. D. Bloch, M. S. Mulligan, J. J. Borsa, and A. B. Fontaine Treatment of Chylothorax: Percutaneous Catheterization and Embolization of the Thoracic Duct Am. J. Roentgenol., April 1, 2001; 176(4): 1040 - 1042. [Full Text] [PDF] |
||||
![]() |
P. Fuentes Invited commentary Ann. Thorac. Surg., February 1, 2001; 71(2): 450 - 451. [Full Text] [PDF] |
||||
![]() |
S. Merigliano, D. Molena, A. Ruol, G. Zaninotto, M. Cagol, S. Scappin, and E. Ancona Reply J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 402 - 403. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |